Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep-Oct;25(7):102863.
doi: 10.1016/j.acap.2025.102863. Epub 2025 Jun 6.

ADHD Medication and Depressive Symptoms in Adolescents: A Retrospective Longitudinal Study

Landon B Krantz  1 , Tanya E Froehlich  2 , Andrew F Beck  3 , Stephen P Becker  4 , Melinda C MacDougall  5 , Shelley Ehrlich  6 , Chidiogo U Anyigbo  7 , Samuel Eggers  8 , William B Brinkman  9
Affiliations

ADHD Medication and Depressive Symptoms in Adolescents: A Retrospective Longitudinal Study

Landon B Krantz et al. Acad Pediatr. 2025 Sep-Oct.

Abstract

Objective: To examine whether higher attention-deficit/hyperactivity disorder (ADHD) medication coverage was associated with lower depressive symptoms among adolescents who live in underresourced neighborhoods and/or identify as a member of a minoritized group.

Methods: In this retrospective cohort study, adolescents aged 12 to 18 years with ADHD completed a depression screener at their annual well visit. Patients were seen at a primary care office that predominantly serves minoritized, Medicaid-insured youth from underresourced neighborhoods. We calculated ADHD medication coverage as the percentage of days in which medication was available in the prior 36 months based on prescriptions in the electronic health record (range 0%-100%). Zero-inflated negative binomial regression models assessed whether medication coverage was associated with differences in total depression scores, measured by the Patient Health Questionnaire.

Results: We included 2569 adolescents (66.6% male, 70.9% Black, 86.6% Medicaid-insured) with 4145 well visits. Medication coverage was poor (mean = 18.5% days covered, standard deviation = 26.8%). Higher medication coverage was not associated with lower depression scores in the overall sample. However, after excluding patients with 0% medication coverage, there was a significant association between higher coverage and lower depression scores. Depression symptom scores were higher in patients with mental/behavioral health comorbidities, those of female sex, and those living in neighborhoods with lower opportunity scores.

Conclusions: Greater ADHD medication coverage was associated with a small, yet potentially clinically significant decrease in depression symptoms in our sample, underscoring the need to investigate the protective effect of ADHD medication on depression in more diverse populations.

Keywords: adolescent mental health; attention-deficit/hyperactivity disorder; depression; social determinants of health.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Dr Brinkman had common stock holdings in the following publicly traded companies until April 2023: Pfizer, Merck, Abbott Laboratories, Viatris, and Johnson & Johnson. No other authors have financial or nonfinancial conflicts of interest to declare.

Similar articles

See all similar articles

References

    1. Libutzki B, Ludwig S, May M, et al. Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis. Eur Psychiatry. 2019;58:38–44. 10.1016/j.eurpsy.2019.01.019 - DOI - PubMed
    1. Daviss WB. A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment. J Child Adolesc Psychopharmacol. 2008;18:565–571. 10.1089/cap.2008.032 - DOI - PMC - PubMed
    1. Garcia-Argibay M, Brikell I, Thapar A, et al. Attention-deficit/hyperactivity disorder and major depressive disorder: evidence from multiple genetically informed designs. Biol Psychiatry. 2024;95:444–452. 10.1016/j.biopsych.2023.07.017 - DOI - PubMed
    1. Mayer JS, Bernhard A, Fann N, et al. Cognitive mechanisms underlying depressive disorders in ADHD: a systematic review. Neurosci Biobehav Rev. 2021;121:307–345. 10.1016/j.neubiorev.2020.12.018 - DOI - PubMed
    1. Rychik N, Fassett-Carman A, Snyder HR. Dependent stress mediates the relation between ADHD symptoms and depression. J Atten Disord. 2021;25:1676–1686. 10.1177/1087054720925900 - DOI - PMC - PubMed

Substances

LinkOut - more resources